Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts


  HIV Infection

  Free Subscription


Articles published in AIDS Res Hum Retroviruses

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    April 2025
  1. CHEN M, Chen H, Dai J, Dong L, et al
    Identification of a Novel Second-Generation HIV-1 Circulating Recombinant Form (CRF174_0708) Arising from CRF07_BC and CRF08_BC in Yunnan, China.
    AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2025.0022.
    PubMed     Abstract available


  2. YU M, Wang X, Jia L, Han J, et al
    Sequence Notes: Identification of Two New CRF01_AE/CRF07_BC Recombinants in Men Who Have Sex with Men Populations in Beijing, China.
    AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2024.0098.
    PubMed     Abstract available


  3. SHEN K, Feng Y, Wang C, Han J, et al
    Sequence Notes: Characterization of the Near-Full-Length Genome of Two Novel Unique Recombinant Genome (CRF01_AE/CRF79_0107, CRF01_AE/CRF07_BC) in Hebei, China.
    AIDS Res Hum Retroviruses. 2025 Apr 10. doi: 10.1089/aid.2024.0127.
    PubMed     Abstract available


  4. WANG L, Yan M, Wumaierjiang R, Zhang Q, et al
    The Association Between the History of Switching Antiretroviral Therapy Regimens and Lipid Profile in People Living with HIV: A Retrospective Study.
    AIDS Res Hum Retroviruses. 2025 Apr 7. doi: 10.1089/aid.2024.0079.
    PubMed     Abstract available


  5. NOLAN DJ, Fogel GB, DaRoza J, Rose R, et al
    Indicators for Increased Likelihood of Epidemic Kaposi Sarcoma Progression after Antiretroviral Therapy Initiation.
    AIDS Res Hum Retroviruses. 2025 Apr 3. doi: 10.1089/aid.2025.0007.
    PubMed     Abstract available


    March 2025
  6. LAN Y, Xie Z, Cao Q, Mai C, et al
    Severe Anemia Is an Independent Risk Factor for In-Hospital Death in Persons Living with HIV in Southern China: A Retrospective Cohort Study.
    AIDS Res Hum Retroviruses. 2025 Mar 19. doi: 10.1089/aid.2024.0095.
    PubMed     Abstract available


  7. SAMRA RS, Griffiths PM, Lee SJ, Smith EL, et al
    Impact of Late HIV Diagnosis on Costs of Care in a Public Health Care Setting.
    AIDS Res Hum Retroviruses. 2025 Mar 19. doi: 10.1089/aid.2024.0100.
    PubMed     Abstract available


    February 2025
  8. ZHANG L, Feng Y, Shen K, Wang L, et al
    Near-Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinants (CRF01_AE/CRF07_BC) and (CRF01_AE/CRF68_01B) in Shijiazhuang, Hebei Province, China.
    AIDS Res Hum Retroviruses. 2025 Feb 18. doi: 10.1089/aid.2024.0114.
    PubMed     Abstract available


  9. SHI Y, Zhang T, Yao H, Wang H, et al
    Molecular Network Characteristics and Drug Resistance Analysis Among Newly Diagnosed Persons Living with HIV-1 in Hefei, China (2017-2022).
    AIDS Res Hum Retroviruses. 2025 Feb 18. doi: 10.1089/aid.2024.0093.
    PubMed     Abstract available


  10. YANG M, Zhang X, Zhang D, Zhang Y, et al
    Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder.
    AIDS Res Hum Retroviruses. 2025 Feb 12. doi: 10.1089/aid.2024.0053.
    PubMed     Abstract available


  11. DUBE K, Patel H, Meanley S, Dee L, et al
    Lessons Learned in Eliciting Systematic Participant Perspectives in a Combination HIV Cure Research Trial.
    AIDS Res Hum Retroviruses. 2025 Feb 5. doi: 10.1089/aid.2024.0086.
    PubMed     Abstract available


  12. CHO YK, Lee J
    Impact of INSTI on a Drug-Resistant Mutation (S68S Insertion) in a Patient Infected with HIV-1 CRF06_cpx.
    AIDS Res Hum Retroviruses. 2025 Feb 3. doi: 10.1089/aid.2024.0107.
    PubMed     Abstract available


  13. O'CONNOR LF, Koay WLA, Unternaher J, Byrne M, et al
    Transient Viremia Among People with HIV Receiving Injectable Cabotegravir Plus Rilpivirine.
    AIDS Res Hum Retroviruses. 2025 Feb 3. doi: 10.1089/aid.2024.0083.
    PubMed     Abstract available


    January 2025
  14. ZHANG Z, Zhang Y, Meng J, Fan W, et al
    Sequence Notes: Characterization of Two Novel HIV-1 Unique Recombinant Forms (CRF01_AE/B) in Hebei Province.
    AIDS Res Hum Retroviruses. 2025 Jan 28. doi: 10.1089/aid.2024.0122.
    PubMed     Abstract available


  15. WANG H, Huang H, Li W, Yuan C, et al
    Near Full-Length Genomic Characterization of a Novel HIV-1 Unique Recombinant (A1/D/K) from an Immigrant Worker in China Using Nanopore Sequencing.
    AIDS Res Hum Retroviruses. 2025 Jan 27. doi: 10.1089/aid.2024.0108.
    PubMed     Abstract available


  16. CHEN S, Shi H, Zhang Z, Yin L, et al
    Sequence Notes: Identification of Three Novel HIV-1 Recombinant Strains with Different Recombination Patterns in Hebei Province, China.
    AIDS Res Hum Retroviruses. 2025 Jan 24. doi: 10.1089/aid.2024.0115.
    PubMed     Abstract available


  17. MEHTA SR, Chaillon A, Wells AB, Little SJ, et al
    Molecular HIV Surveillance: Beyond Cluster Detection and Response.
    AIDS Res Hum Retroviruses. 2025 Jan 24. doi: 10.1089/aid.2024.0084.
    PubMed     Abstract available


  18. WANG X, Zhu B, Li H, Han J, et al
    Identification of a Novel HIV-1 Second-Generation Circulating Recombinant Form (CRF117_0107) in China.
    AIDS Res Hum Retroviruses. 2025 Jan 17. doi: 10.1089/aid.2024.0106.
    PubMed     Abstract available


  19. CAO B, Liu M, Song S, Guo M, et al
    HIV-1 DNA Genotypic Drug Resistance Testing Guides Antiretroviral Therapy in Patients with Low-Level Viremia.
    AIDS Res Hum Retroviruses. 2025 Jan 15. doi: 10.1089/aid.2024.0088.
    PubMed     Abstract available


  20. GUAN Y, Wang J, Liu M, Lu X, et al
    Confirmation of Two Novel HIV-1 CRF01_AE/CRF07_BC Recombinant Forms Among Men Who Have Sex with Men in Hebei, China.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0104.
    PubMed     Abstract available


  21. HIJONA ELOSEGUI JJ, Carballo Garcia AL, Fernandez Risquez AC, Presa Lorite JC, et al
    Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0067.
    PubMed     Abstract available


  22. CHEN M, Chen H, Dai J, Dong L, et al
    Characterization of an Invisible HIV-1 Circulating Recombinant Form (CRF149_01B) in China.
    AIDS Res Hum Retroviruses. 2025 Jan 8. doi: 10.1089/aid.2024.0099.
    PubMed     Abstract available


    December 2024
  23. KUMMET N, Mishra N, Diaz A, Cusick N, et al
    Genetic Characterization of HIV-1 tat Gene from Virologically Controlled Aging Individuals with HIV on Long-Term Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2024 Dec 26. doi: 10.1089/aid.2024.0029.
    PubMed     Abstract available


  24. CAO B, Liu M, Song S, Ding P, et al
    Comparison of HIV-1 RNA and HIV-1 DNA Genotypic Drug Resistance Testing in Women of Childbearing Age Infected with HIV-1 in Liangshan Prefecture.
    AIDS Res Hum Retroviruses. 2024 Dec 24. doi: 10.1089/aid.2024.0001.
    PubMed     Abstract available


  25. GOODMAN GR, Overstreet DS, Wilson JM, O'Cleirigh C, et al
    Acceptability of a Smartphone-Based Music Intervention for Chronic Pain and Problematic Opioid Use Among People with HIV: A Mixed-Methods Pilot Study.
    AIDS Res Hum Retroviruses. 2024 Dec 23. doi: 10.1089/aid.2024.0072.
    PubMed     Abstract available


  26. KINGSTON H, Chohan BH, Mbogo L, Bukusi D, et al
    Using HIV and Hepatitis C Molecular Epidemiology to Investigate Assisted Partner Services Recruitment Among People Who Inject Drugs in Kenya.
    AIDS Res Hum Retroviruses. 2024 Dec 16. doi: 10.1089/aid.2024.0036.
    PubMed     Abstract available


  27. MA Y, Zhang J, Xiao J, Yang X, et al
    Association Between Dynamic Viral Rebound and Longitudinal Measures of Viral Load/CD4 Counts Among People with HIV in South Carolina.
    AIDS Res Hum Retroviruses. 2024 Dec 16. doi: 10.1089/aid.2024.0035.
    PubMed     Abstract available


  28. CARIAS AM, Anderson M, McRaven M, Allen E, et al
    Transcytosis as a Mechanism of HIV-1 Entry into Columnar Epithelial Explants of the Female Reproductive Tract.
    AIDS Res Hum Retroviruses. 2024 Dec 12. doi: 10.1089/aid.2024.0045.
    PubMed     Abstract available


  29. LI M, Guan H, Zhong M, Di X, et al
    Willingness to Switch to Long-Acting Injectable Cabotegravir and Rilpivirine Every 2 Months for People Living with HIV in Nanjing, China.
    AIDS Res Hum Retroviruses. 2024 Dec 12. doi: 10.1089/aid.2023.0150.
    PubMed     Abstract available


  30. HILMI S, Ouladlahsen A, Bencharki B, Haddaji A, et al
    The rs1799884 Glucokinase Gene Polymorphism Modulates Susceptibility to HIV Status and CD4 Cell Count and Viral Load before and After Treatment in AIDS Progressors.
    AIDS Res Hum Retroviruses. 2024 Dec 11. doi: 10.1089/aid.2024.0009.
    PubMed     Abstract available


    November 2024
  31. HUANG S, Qing Y, Deng Y, Deng L, et al
    The Risk Factors of High-Risk Human Papillomavirus Susceptibility and Clinical Features in HIV-Positive Patients with Anal Condyloma Acuminatum: A Retrospective Cohort Study.
    AIDS Res Hum Retroviruses. 2024 Nov 18. doi: 10.1089/aid.2024.0051.
    PubMed     Abstract available


  32. JIN L, Hu R, Qing Y, Rang Z, et al
    Exploring the Role of Gut Vascular Barrier Proteins in HIV-Induced Mucosal Damage: A Comparative Study.
    AIDS Res Hum Retroviruses. 2024 Nov 6. doi: 10.1089/aid.2024.0077.
    PubMed     Abstract available


    October 2024
  33. CICCULLO A, Iannone V, Farinacci D, Steiner RJ, et al
    Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.
    AIDS Res Hum Retroviruses. 2024 Oct 29. doi: 10.1089/aid.2024.0066.
    PubMed     Abstract available


  34. ROMERO-RODRIGUEZ DP, Romero-Rodriguez J, Cervantes-Mejia F, Olvera-Garcia G, et al
    Central Memory CD4 T Cells from Persons with HIV Accumulate DNA Content Defects During Proliferative Response.
    AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0062.
    PubMed     Abstract available


  35. SUCUPIRA MCA, Schechter M, Castelo Filho A, Ferreira F, et al
    Comparison of the Performance of Commercially Available Quantitative Viral Load Assays Using Clinical Samples from Patients from Regions Where Distinct HIV-1 Subtypes Co-Circulate: Potential Implications for Patient Management.
    AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0055.
    PubMed     Abstract available


  36. FOGEL JM, Persaud D, Piwowar-Manning E, Richardson P, et al
    HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.
    AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0049.
    PubMed     Abstract available


  37. LEFEBVRE S, Lelievre JD, Rieux V, Weiss L, et al
    "They Have to Make an Effort Too": What Decliners Can Teach Us About HIV Cure/Remission-Related Clinical Trials? Results from a French Qualitative Study.
    AIDS Res Hum Retroviruses. 2024 Oct 22. doi: 10.1089/aid.2024.0064.
    PubMed     Abstract available


  38. EDWARDS J, Boyce G, Lyons N, Todd S, et al
    Long-Term Follow-Up of Persons Living with Perinatally Acquired HIV Infection at a Large HIV Treatment Clinic in Trinidad.
    AIDS Res Hum Retroviruses. 2024 Oct 17. doi: 10.1089/aid.2024.0052.
    PubMed     Abstract available


  39. CHENG P, He BC, Wu ZX, Liu JF, et al
    Interpreting the Epidemiological Characteristics of HIV-1 in Heterosexually Transmitted Population Based on Molecular Transmission Network in Kunming, Yunnan: A Retrospective Cohort Study.
    AIDS Res Hum Retroviruses. 2024 Oct 17. doi: 10.1089/aid.2023.0137.
    PubMed     Abstract available


    September 2024
  40. SCHURMANN D, Hueser A, Pfaefflin F, Cilissen C, et al
    A Randomized, Double-blind, Placebo-controlled, Short-term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), in Treatment-Naive HIV-Infected Participants.
    AIDS Res Hum Retroviruses. 2024 Sep 18. doi: 10.1089/AID.2023.0152.
    PubMed     Abstract available


  41. SU X, Freeman M
    CD57+ T cell transmigration through vascular endothelial cells is enhanced by TNF: A novel model of cardiovascular risk in people with HIV.
    AIDS Res Hum Retroviruses. 2024 Sep 18. doi: 10.1089/AID.2024.0057.
    PubMed     Abstract available


  42. JIA J, Yang H, Zhang Z, Shi H, et al
    Characterization of Two Novel HIV-1 CRF01_AE/ CRF07_BC Recombinant Forms Among Men Who Have Sex with Men and Mother-to-Child Transmission Cases in Baoding City, China.
    AIDS Res Hum Retroviruses. 2024 Sep 18. doi: 10.1089/AID.2024.0059.
    PubMed     Abstract available


  43. WALMSLEY S
    Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for AIDS Research and Human Retroviruses.
    AIDS Res Hum Retroviruses. 2024;40:501.
    PubMed    


    August 2024
  44. NGUYEN L, Leach A, Piwowar-Manning E, Marzinke MA, et al
    Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.
    AIDS Res Hum Retroviruses. 2024 Aug 13. doi: 10.1089/AID.2024.0042.
    PubMed     Abstract available


  45. CHEN M, Chen H, Dai J, Dong L, et al
    Identification of a novel HIV-1 circulating recombinant form (CRF150_cpx) among men who have sex with men in China.
    AIDS Res Hum Retroviruses. 2024 Aug 8. doi: 10.1089/AID.2024.0061.
    PubMed     Abstract available


  46. TAYLOR R, Xiao S, Carias AM, McRaven MD, et al
    PET/CT targeted tissue sampling reveals intravenously administered HGN194 IgG1 affects HIV distribution after rectal exposure.
    AIDS Res Hum Retroviruses. 2024 Aug 6. doi: 10.1089/AID.2024.0019.
    PubMed     Abstract available


    July 2024
  47. RODRIGUEZ-LOPEZ E, Lopez P, Rodriguez Y, Sanchez R, et al
    HIV-1 integrase T218I/S polymorphisms do not reduce HIV-1 integrase inhibitors' phenotypic susceptibility.
    AIDS Res Hum Retroviruses. 2024 Jul 31. doi: 10.1089/AID.2023.0128.
    PubMed     Abstract available


  48. CHEN X
    DISSyphilis and the risk of HIV infection: A Mendelian randomization study.
    AIDS Res Hum Retroviruses. 2024 Jul 31. doi: 10.1089/AID.2024.0005.
    PubMed     Abstract available


  49. SUGAWARA S, Lee E, Craemer M, Pruitt A, et al
    Knockdowns of CD3zeta chain in Primary NK Cells Illustrate Modulation of Antibody-Dependent Cellular Cytotoxicity against Human Immunodeficiency Virus-1.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2023.0114.
    PubMed     Abstract available


  50. GOVINDARAJ S, Ibegbu C, Ali SA, Babu H, et al
    IL-15/IL-15Ra synergies with IL-12 to induce functional CD8 T cells and NK cells during chronic SHIV infection.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2024.0043.
    PubMed     Abstract available


  51. MATSUDA EM, da Silva Santos JH, Ahagon CM, Lopes GISL, et al
    Transmitted antiretroviral drug resistance to Integrase Strand Transfer Inhibitors class in Sao Paulo metropolitan area, Brazil.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2023.0127.
    PubMed     Abstract available


  52. GAO X, Wang C, Li L, Feng Y, et al
    Identification of two novel HIV-1 unique recombinant forms (CRF01_AE/CRF07_BC) and genomic characterization in Tongzhou district of Beijing, China.
    AIDS Res Hum Retroviruses. 2024 Jul 14. doi: 10.1089/AID.2024.0044.
    PubMed     Abstract available


  53. DAS D, Lopez-Rios J, McKenna S, Porter J, et al
    Improving Recruitment and Retention of Transgender Women in HIV Prevention Trials: Strategies to Make Trials Participation More Congruent with the Needs of Transgender Women.
    AIDS Res Hum Retroviruses. 2024 Jul 14. doi: 10.1089/AID.2023.0063.
    PubMed     Abstract available


  54. MASTERS MC, Campbell LM, Yu J, Heaton A, et al
    Postural stability as a measure of fall risk in older people with and without HIV.
    AIDS Res Hum Retroviruses. 2024 Jul 8. doi: 10.1089/AID.2024.0046.
    PubMed     Abstract available


  55. ROSS LL, Cotton M, Cassim H, Garges HP, et al
    Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living With HIV-1 Treated With Ritonavir-Boosted Fosamprenavir Oral Solution-Based Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2024 Jul 8. doi: 10.1089/AID.2024.0020.
    PubMed     Abstract available


  56. WANG Y, Yang C, Jin X, Chen H, et al
    HIV-1 molecular networks and pretreatment drug resistance at the frontier of Yunnan Province, China.
    AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2023.0124.
    PubMed     Abstract available


  57. BBOSA N, Holzmayer V, Ssemwanga D, Downing R, et al
    Near full-length genome analysis of the first-reported HIV-1 Circulating Recombinant Form (CRF)_10CD in Uganda.
    AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0034.
    PubMed     Abstract available


  58. BYRNE M, Resnik J, Horberg M, Greenberg AE, et al
    Factors associated with time to initial antiretroviral regimen discontinuation in the DC Cohort.
    AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0002.
    PubMed     Abstract available


  59. HASER GC, Balter LB, Gurley SA, Thomas M, et al
    Early Implementation and Outcomes Among People with HIV who Accessed Long Acting Injectable-Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.
    AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0007.
    PubMed     Abstract available


    June 2024
  60. NOLAN D, DaRoza J, Brody R, Ganta K, et al
    Comparing Gold-Standard Sanger Sequencing with Two Next-Generation Sequencing Platforms of HIV-1 gp160 Single Template Amplicons.
    AIDS Res Hum Retroviruses. 2024 Jun 28. doi: 10.1089/AID.2024.0012.
    PubMed     Abstract available


  61. INCEER M, Boehnke J, Brouillette MJ, Fellows LK, et al
    In Support of Multidimensional Frailty: A Structural Equation Model from the Canadian Positive Brain Health Now Cohort.
    AIDS Res Hum Retroviruses. 2024 Jun 15. doi: 10.1089/AID.2023.0126.
    PubMed     Abstract available


  62. MELKUNTE SHANTHAIAH D, Chitkara A, Murthy S, Srivastava D, et al
    Evaluation of urinary free light chains as a marker of severity of HIV disease and its correlation with CD4 count: A Pilot Study.
    AIDS Res Hum Retroviruses. 2024 Jun 6. doi: 10.1089/AID.2023.0100.
    PubMed     Abstract available


  63. PIRSL F, Calkins K, Rudolph J, Wentz E, et al
    Receipt of prostate-specific antigen test in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
    AIDS Res Hum Retroviruses. 2024 Jun 6. doi: 10.1089/AID.2023.0142.
    PubMed     Abstract available


    May 2024
  64. CAO B, Wu C, Liu M, Song S, et al
    Molecular transmission network and drug resistance in treatment-naive HIV-1 infected patients in the Liangshan District, China.
    AIDS Res Hum Retroviruses. 2024 May 24. doi: 10.1089/AID.2024.0016.
    PubMed     Abstract available


  65. DING A, Wallis Z, White K, Efe C, et al
    Galectin-3, galectin-9, and IL-18 are associated with monocyte activation and turnover more so than SIV-associated cardiac pathology or encephalitis.
    AIDS Res Hum Retroviruses. 2024 May 24. doi: 10.1089/AID.2024.0008.
    PubMed     Abstract available


  66. RUTAYISIRE G, Ssemwanga E, Ntale R, Grace UM, et al
    In Utero Mother-to-Child Transmission of HIV-1 and the Associated Factors in Rwanda, Africa.
    AIDS Res Hum Retroviruses. 2024 May 21. doi: 10.1089/aid.2023.0117.
    PubMed     Abstract available


  67. TAGLIAFERRI RAEL C, Giguere R, Bryndza Tfaily E, Sutton S, et al
    The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men (GBM) and Physicians.
    AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2023.0120.
    PubMed     Abstract available


  68. MISHRA T, Phillips S, Maldonado C, Stapleton J, et al
    Antiretroviral therapy suppresses RNA N6-methyladenosine modification in peripheral blood mononuclear cells from HIV-1-infected individuals.
    AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0003.
    PubMed     Abstract available


  69. GUO L, Fu Y, Xie X, Yan W, et al
    Comparative on the Efficacy and Safety of ANV-Based Versus EFV-Based ART in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China.
    AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0030.
    PubMed     Abstract available


  70. WOOLLEY G, Kroll K, Hoffman K, Ward A, et al
    The Climate Change Burden on Immune Health: Are Persons Living With HIV More at Risk?
    AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0050.
    PubMed     Abstract available


  71. MAINELLA V, Morrow M, Brooks K, Bushman L, et al
    Intracellular Islatravir-Triphosphate in Dried Blood Spots and Peripheral Blood Mononuclear Cells from Pig-Tailed Macaques.
    AIDS Res Hum Retroviruses. 2024;40:227-230.
    PubMed     Abstract available


    April 2024
  72. HAYASHIDA T, Tran LK, Dang AL, Nagai M, et al
    Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam.
    AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2024.0022.
    PubMed     Abstract available


  73. LI W, Feng Y, Han J, Wang X, et al
    Characterization of two HIV-1 strains with novel unique recombinant genome in Hebei, China.
    AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2024.0006.
    PubMed     Abstract available


  74. OLIVA-SANCHEZ PF, Landeros-Lopez S, Rosas-Dossetti MM, Grobeisen-Levin S, et al
    Comparison of four predictive scores for cardiovascular risk in Mexican people living with HIV.
    AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2023.0085.
    PubMed     Abstract available


    March 2024
  75. GHASSABI F, Hashempour A, Dehghani B, Hasanshahi Z, et al
    Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naive HIV Patients.
    AIDS Res Hum Retroviruses. 2024 Mar 30. doi: 10.1089/AID.2023.0102.
    PubMed     Abstract available


  76. RENRONG T, Li T, Zhang MX, Song TZ, et al
    Nonnegligible contribution of non-lymphoid tissue to viral reservoir during the short-term early cART in SIVmac239-infected Chinese rhesus macaques.
    AIDS Res Hum Retroviruses. 2024 Mar 27. doi: 10.1089/AID.2023.0130.
    PubMed     Abstract available


  77. LAN C, Zhu B, Hailong Z, Yuting S, et al
    Near Full-Length Genome Characterization of two Novel Unique Recombinants (CRF01_AE/CRF07_BC) in Beijing, China.
    AIDS Res Hum Retroviruses. 2024 Mar 22. doi: 10.1089/AID.2023.0149.
    PubMed     Abstract available


  78. LE BRAZIDEC DL, Cormier K, Almonte A, Napoleon S, et al
    Pre-Exposure Prophylaxis Care Cascade Among Men Who Have Sex with Men Engaging in Partner Notification Services at a Sexually Transmitted Infections Clinic.
    AIDS Res Hum Retroviruses. 2024 Mar 18. doi: 10.1089/aid.2023.0097.
    PubMed     Abstract available


  79. WOHLFEILER MB, Weber RP, Brunet L, Siddiqui J, et al
    Incident HIV-Associated Wasting/Low Weight is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
    AIDS Res Hum Retroviruses. 2024 Mar 14. doi: 10.1089/AID.2023.0113.
    PubMed     Abstract available


  80. FOLGOSI VA, Konminakis SV, Silva FDD, Leite Junior PD, et al
    Evaluation of the New Multi-HTLV Serological Assay: Improvement for HTLV-2 Detection.
    AIDS Res Hum Retroviruses. 2024;40:134-140.
    PubMed     Abstract available


  81. FAJAMI Z, Akbarin MM, Rafatpanah H, Ramezani S, et al
    Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients.
    AIDS Res Hum Retroviruses. 2024;40:141-147.
    PubMed     Abstract available


    February 2024
  82. GENG H, Liu B, Liu Y, Chen S, et al
    Identification of the near full-length genome of a novel HIV-1 CRF01_AE/CRF07_BC recombinant in Hebei Province, China.
    AIDS Res Hum Retroviruses. 2024 Feb 26. doi: 10.1089/AID.2023.0119.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.